Medpace (MEDP) Proxy filing summary

Executive summary

• Annual meeting scheduled for May 15, 2026, with virtual participation available to shareholders.

• Shareholders are encouraged to review proxy materials and vote by May 14, 2026.

Voting matters and shareholder proposals

• Election of five directors: Brian T. Carley, Femida H. Gwadry-Sridhar, Robert O. Kraft, August J. Troendle, and Dani S. Zander.

• Ratification of Deloitte & Touche LLP as independent auditor for fiscal year ending December 31, 2026.

• Advisory vote on executive compensation and on the frequency of future say-on-pay votes.

• Proposal to amend the Certificate of Incorporation to remove supermajority voting requirements.

• Proposal to amend the Certificate of Incorporation to remove the limitation on shareholders calling special meetings.

• Shareholder proposal regarding the ability to call special shareholder meetings.

Board of directors and corporate governance

• Board recommends voting for all director nominees and for the removal of supermajority voting requirements.

• Board recommends against the shareholder proposal on special meetings.